$42.00
Additional information
| Water Retention | Not typically associated | 
|---|---|
| Hepatotoxicity | Mild to moderate potential | 
| Lab Test | Monitoring of blood counts and renal function | 
| Also known as | SDX-105 | 
| Blood pressure | Potential for hypertension | 
| Trade name | Treanda, Bendeka | 
| Storage conditions | Store at 25В°C (77В°F), excursions permitted to 15-30В°C (59-86В°F) | 
| Chemical name | 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid | 
| Formula | C16H21Cl2N3O2 | 
| Substance class | Alkylating agent | 
| Main action | Antineoplastic | 
| Half-life | Approximately 40 minutes | 
| Dosage (medical) | Typically 100 mg/mВІ on days 1 and 2 of a 28-day cycle, intravenously | 
| Dosage (sports) | Not applicable | 
| Effects | Induces breaks in DNA strands, leading to cell death | 
| Side effects | Myelosuppression, nausea, vomiting, diarrhea, fatigue, fever, anemia | 
| Use in sports | None | 
| Manufacturer | Pharmaceutical | 





